Related content

Characteristics, Treatment and Outcome of Patients with Non-ST-Elevation Acute Coronary Syndromes and Multivessel Coronary Artery Disease: Observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy)

By  

Cardiology, Vol. 98, Iss. 4, 2003-01 ,pp. : 195-201

Karger

Access to resources Recommend Favorite

Use of Glycoprotein IIb/IIIa Inhibitors in Patients with Acute Coronary Syndromes Undergoing Coronary Revascularization

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 69-71

Karger

Access to resources Recommend Favorite

A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 330-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants*

By Happe Laura E.   Rao Sunil V.   Horblyuk Ruslan   Franklin Meg   Lunacsek Orsolya E.   Menditto Laura  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 413-420

Informa Healthcare

Access to resources Recommend Favorite

A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome

By Alzuhairi Karam S. M.   Hjortshøøj Søøren   Kristensen Søøren Risom   Ravkilde Jan  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 2, 2011-04 ,pp. : 117-122

Informa Healthcare

Access to resources Recommend Favorite